- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07387133
Parental Technoference and Behavioral-Emotional Development in Early Childhood: A 6-Month Prospective Study (TECH-SDQ)
Early Childhood Parental Technoference and Behavioral-Emotional Development: A Six-Month Prospective Study
This study aims to examine the relationship between parental technoference (parents' use of smartphones or other digital devices while spending time with their children) and behavioral and emotional development in early childhood.
The study will include parents of children aged 24 to 60 months who attend a pediatric outpatient clinic. At the beginning of the study, parents will complete an online questionnaire that includes questions about their own smartphone screen time, their child's screen exposure, and standardized questionnaires assessing parental technoference and children's behavioral and emotional characteristics.
Six months after the initial assessment, parents will be contacted again to complete a short follow-up questionnaire, including the behavioral and emotional assessment. The study does not involve any medical intervention or experimental treatment. All participation is voluntary, and responses will be collected anonymously.
The findings of this study are expected to contribute to a better understanding of how parental digital device use during daily interactions may be associated with children's emotional and behavioral development in early childhood.
Study Overview
Status
Detailed Description
This is a single-center, prospective observational study conducted among parents of children aged 24 to 60 months attending a pediatric outpatient clinic at a tertiary training and research hospital.
Parental technoference is defined as interruptions in parent-child interactions due to parental use of smartphones or other digital devices. At baseline, participating parents will complete an online questionnaire that includes sociodemographic characteristics, self-reported average daily smartphone screen time over the previous seven days (recorded from the device's built-in screen time or digital wellbeing function), and information about the child's daily screen exposure.
Parental technoference will be assessed using a validated parental technoference scale, and children's behavioral and emotional characteristics will be evaluated using the parent-report version of the Strengths and Difficulties Questionnaire (SDQ) for preschool-aged children. Both instruments have established validity and reliability in the Turkish population.
At the end of the baseline assessment, parents will be provided with a brief informational message aimed at increasing awareness of digital distractions during parent-child interactions. No behavioral intervention will be enforced as part of the study.
Six months after the initial assessment, parents will be re-contacted via phone or email and invited to complete a follow-up questionnaire, including the SDQ and updated information on parental and child screen exposure. The primary outcome is the association between parental technoference levels and children's behavioral and emotional outcomes. Secondary outcomes include changes in SDQ scores over the six-month follow-up period.
All data will be collected anonymously and analyzed using appropriate statistical methods, including correlation analyses and multivariable regression models. This study involves no medical intervention and poses minimal risk to participants.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: timucin imdadoglu, MD
- Phone Number: +905357426892
- Email: dr.timucini@gmail.com
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Sancaktepe Prof. Dr. Ilhan Varank Training and Research Hospital
-
Contact:
- timucin imdadoglu, MD
- Phone Number: +905357426892
- Email: dr.timucini@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children aged 24 to 60 months.
- Parent or primary caregiver able to read and understand Turkish.
- Parent uses a smartphone and can access device-based screen time information.
- Ability to complete an online questionnaire.
- Provision of written informed consent by the parent or legal guardian.
- Availability for a 6-month follow-up assessment.
Exclusion Criteria:
- Children with severe neurodevelopmental disorders (e.g., autism spectrum disorder, severe intellectual disability, neurometabolic diseases).
- Parents unable to reliably complete questionnaires due to cognitive, psychiatric, or language-related limitations.
- Parents who do not use a smartphone or cannot access screen time data.
- Refusal or inability to provide informed consent.
- Inability to be contacted for follow-up assessment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Parent-Child Dyads (24-60 Months)
This cohort includes parents and their children aged 24 to 60 months who attend a pediatric outpatient clinic at a tertiary training and research hospital.
Participants are assessed at baseline using questionnaires evaluating parental technoference, parental and child screen time, and children's behavioral and emotional characteristics.
A follow-up assessment is conducted six months later.
This is an observational study, and no intervention is assigned.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child Behavioral and Emotional Difficulties (SDQ Total Difficulties Score)
Time Frame: Baseline and 6 months
|
Children's behavioral and emotional difficulties will be assessed using the parent-report version of the Strengths and Difficulties Questionnaire (SDQ).
The primary outcome is the SDQ Total Difficulties Score measured at baseline and at 6-month follow-up.
|
Baseline and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental Technoference Level
Time Frame: Baseline
|
Parental technoference will be measured using a validated parental technoference scale assessing the frequency of digital device-related interruptions during parent-child interactions.
|
Baseline
|
|
Changes in Children's Behavioral and Emotional Characteristics Over Time
Time Frame: Baseline to 6 months
|
Changes in children's behavioral and emotional characteristics will be evaluated by comparing SDQ Total Difficulties and subscale scores between baseline and the 6-month follow-up assessment.
|
Baseline to 6 months
|
|
Child Screen Exposure
Time Frame: Baseline and 6 months
|
Child screen exposure will be assessed based on parent-reported average daily screen time across different digital media devices.
|
Baseline and 6 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997 Jul;38(5):581-6. doi: 10.1111/j.1469-7610.1997.tb01545.x.
- Moemenbellah-Fard MD, Shahriari B, Azizi K, Fakoorziba MR, Mohammadi J, Amin M. Faunal distribution of fleas and their blood-feeding preferences using enzyme-linked immunosorbent assays from farm animals and human shelters in a new rural region of southern Iran. J Parasit Dis. 2016 Mar;40(1):169-75. doi: 10.1007/s12639-014-0471-1. Epub 2014 May 25.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TEKNOFERANS-SDQ-2026
- EthicsNo-2026/19-Sancaktepe (Other Identifier: Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital Ethics Committee)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parental Technoference
-
University of NottinghamNot yet recruitingParental ImprisonmentUnited Kingdom
-
Children's Mercy Hospital Kansas CityCompleted
-
Lusofona UniversityFundação para a Ciência e a Tecnologia; FUNDAÇAO CALOUSTE GULBENKIAN; Santa Casa... and other collaboratorsRecruitingParental Emotion Socialization | Parents' Beliefs About and Reactions to Children's Emotions | Parental Emotion RegulationPortugal
-
Universiteit AntwerpenKU Leuven; OpgroeienNot yet recruitingParental Stress | Infant Regulatory Problems | Regulatory Problems in Infancy | Parental Self-efficacyBelgium
-
Massachusetts General HospitalRobert Wood Johnson FoundationCompletedTobacco Use | Parental SmokingUnited States
-
University of ChicagoCompleted
-
University of CopenhagenKøbenhavns Kommune; Aarhus Kommune; Hvidovre Kommune; Horsholm Municipality; Samarbejde... and other collaboratorsRecruitingParental Divorce | Parental Relationship Dissolution | Mental Health and Well-beingDenmark
-
Centre Hospitalier Universitaire DijonCompletedExpanded Newborn Screening | Parental AcceptabilityFrance
-
University of California, Los AngelesConrad N. Hilton Foundation; City of Pomona; FORWARD PlatformActive, not recruitingParental Stress | Mental Health | Early Child Well-being | Family Economic Security | Parental/Caregiver HealthUnited States
-
Boston Medical CenterWithdrawnParental/Patient SatisfactionUnited States